Open AccessBisphosphonates: An update to the general dentist
Author(s) -
Varun Dahiya,
Pradeep Shukla,
Shivangi Gupta
Publication year - 2013
Publication title -
dental hypotheses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.164
H-Index - 10
ISSN - 2155-8213
DOI - 10.4103/2155-8213.113001
Subject(s) - medicine , dentistry , osteoporosis , osteonecrosis of the jaw , bone resorption , bone density conservation agents , complication , bisphosphonate , diphosphonates , skeletal disorder , bone density
Bisphosphonates (BP), included under host modulation therapy are drugs that inhibit bone resorption and commonly prescribed to prevent skeletal related changes in malignant diseases of bone and bone diseases such as osteoporosis. The sudden rise of this group of drugs is unfortunately because of the serious complication of osteonecrosis of jaws called Bisphosphonate related osteonecrosis of jaws which leads to many dental related complications. This literature review is undertaken to review the general recommendations to the dentist and clinical implications of BP′s. The implications of BP′s use in dentistry are still being determined